104 related articles for article (PubMed ID: 27639532)
1. Biomarkers in Genitourinary Cancers: Blazing the Path Forward.
Pal SK; Karam JA; Chennamsetty A; Jones JO
Eur Urol; 2017 Feb; 71(2):247-248. PubMed ID: 27639532
[No Abstract] [Full Text] [Related]
2. Predictive medicine: Using circulating biomarkers to guide management of patients with genitourinary cancers.
Armstrong AJ
Urol Oncol; 2016 Nov; 34(11):488-489. PubMed ID: 27793467
[No Abstract] [Full Text] [Related]
3. Morphology and biomarkers in genitourinary cancers. Introduction to the symposium.
Volavšek M; Montironi R
Anal Quant Cytopathol Histpathol; 2015 Feb; 37(1):1-2. PubMed ID: 26072628
[No Abstract] [Full Text] [Related]
4. [Concerns in genitourinary cancers].
LONGORIA J
Cir Cir; 1959 Jan; 27(1):36-8. PubMed ID: 13629838
[No Abstract] [Full Text] [Related]
5. Surgical therapy of genitourinary cancers.
Patel VR
Expert Rev Anticancer Ther; 2007 Sep; 7(9):1267. PubMed ID: 17892426
[No Abstract] [Full Text] [Related]
6. Immunotherapy for genitourinary malignancies in the here and now!
Slovin SF
Urol Oncol; 2016 Apr; 34(4):169-70. PubMed ID: 26705103
[No Abstract] [Full Text] [Related]
7. Imaging of genitourinary cancers: progress on all fronts.
Rouvière O
Diagn Interv Imaging; 2012 Apr; 93(4):219-20. PubMed ID: 22516456
[No Abstract] [Full Text] [Related]
8. [Early detection of urogenital cancers: kidney, bladder, prostatic and testicular cancers].
Kawai T; Yamauchi T; Tachibana Y; Yoshino S; Kokuho M
Gan No Rinsho; 1988 Aug; 34(10):1403-7. PubMed ID: 3172497
[TBL] [Abstract][Full Text] [Related]
9. Genitourinary cancers.
Krueger H; McLean D; Williams D
Prog Exp Tumor Res; 2008; 40():92-101. PubMed ID: 18802392
[No Abstract] [Full Text] [Related]
10. Spontaneous regression of genitourinary cancers.
Schirmer HK
Natl Cancer Inst Monogr; 1976 Nov; 44():19. PubMed ID: 799757
[TBL] [Abstract][Full Text] [Related]
11. New developments in chemotherapy of genitourinary cancers.
Brubaker LH
J Med Assoc Ga; 1978 Jun; 68(6):489-90. PubMed ID: 750652
[No Abstract] [Full Text] [Related]
12. Immunotargeting and personalized therapies in genitourinary cancers.
Mazzucchelli R; Gasparrini S; Galosi AB; Massari F; Ciccarese C; Scarpelli M; Lopez-Beltran A; Cheng L; Montironi R
Future Oncol; 2016 Aug; 12(16):1853-6. PubMed ID: 27113700
[No Abstract] [Full Text] [Related]
13. Genitourinary cancers in Minnesota.
Blackard CE
Minn Med; 1971 Jul; 5(7):497-8. PubMed ID: 5105690
[No Abstract] [Full Text] [Related]
14. Editorial comment: Targeted therapies for genitourinary cancers: dream or reality?
Gil-Bazo I
Arch Esp Urol; 2010 Nov; 63(9):788-9. PubMed ID: 21098903
[No Abstract] [Full Text] [Related]
15. Nanoparticle imaging for genitourinary cancers.
Eisner BH; Feldman AS
Cancer Biomark; 2009; 5(2):75-9. PubMed ID: 19414924
[TBL] [Abstract][Full Text] [Related]
16. Leveraging the Tumor Immune Microenvironment To Overcome Genitourinary Cancers.
Bellone M; Mondino A
Eur Urol Oncol; 2023 Jun; 6(3):273-274. PubMed ID: 37147215
[No Abstract] [Full Text] [Related]
17. Burden of metastatic bone disease from genitourinary malignancies.
Mulders PF; Abrahamsson PA; Bukowski RM
Expert Rev Anticancer Ther; 2010 Nov; 10(11):1721-33. PubMed ID: 21080800
[TBL] [Abstract][Full Text] [Related]
18. Applications of PET/MR Imaging in Urogynecologic and Genitourinary Cancers.
Oldan JD; Shah SN; Rose TL
Magn Reson Imaging Clin N Am; 2017 May; 25(2):335-350. PubMed ID: 28390533
[TBL] [Abstract][Full Text] [Related]
19. Genitourinary Cancers Other than Prostate Cancer in a BRCA-tested Cohort from a Single Institution.
Alanee S; Schrader K; Offit K
Eur Urol; 2015 Jun; 67(6):1196-1197. PubMed ID: 25597019
[No Abstract] [Full Text] [Related]
20. 2019 ASCO Genitourinary Cancers Symposium.
Bradley CA
Nat Rev Urol; 2019 Apr; 16(4):207. PubMed ID: 30833753
[No Abstract] [Full Text] [Related]
[Next] [New Search]
